Halozyme Therapeutics, Inc.

Direct answer

Halozyme Therapeutics, Inc. is publicly traded on NASDAQ under the ticker HALO.

Halozyme Therapeutics, Inc. is a biopharmaceutical company headquartered in San Diego, California, with operations spanning the United States, Switzerland, Ireland, Belgium, Japan, and other international markets. At its core is the proprietary ENHANZE drug delivery platform, which utilizes a patented recombinant human hyaluronidase enzyme (rHuPH20). This innovative technology significantly enhances the subcutaneous...

Can you invest in Halozyme Therapeutics, Inc.?

Yes. Halozyme Therapeutics, Inc. trades publicly on NASDAQ as HALO.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Halozyme Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.